REPOSITRAK, INC.

TRAK

CIK 0000050471 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$6M
↑+6.7% +$366Kvs FY2024 (Q4)
Operating Income
$2M
↑+34.4% +$465Kvs FY2024 (Q4)
Net Income
$2M
↑+41.9% +$498Kvs FY2024 (Q4)
Gross Profit
$5M
↑+11.5% +$515Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
48/100
  • Profitability
    34ROIC 11.8% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 6.09 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    17Asset Turnover 0.42x (1.0+ = capital-efficient)
  • Growth
    39Revenue YoY +6.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 31.0% · trend +4.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project TRAK's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

12%

Trailing 3-yr CAGR was 11.6%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$8.88
Total enterprise IV
$170M
Diluted shares
0.02B
Terminal PV
$126M (74% of total)
Year-5 FCF
$15M
YearProjected FCFDiscounted PV
+1$9M$9M
+2$11M$9M
+3$12M$9M
+4$13M$9M
+5$15M$9M
Terminal$202M$126M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$28K
investment in PP&E
Dividends paid (TTM)
$2M
cash returned to holders
Stock buybacks (TTM)
$1M
share count reduction
Stock-based comp (TTM)
$458K
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$56M
everything owned
Total liabilities
$7M
everything owed
Stockholders' equity
$50M
shareholder claim

Recent performance · 63 quarters

Revenue↑+6.7% +$366K
$6M
Net Income↑+8.7% +$135K
$2M
Free Cash Flow↓-35.3% -$1M
$2M
Operating Margin↑+6.4pts
31.0%

Drill down